RELENZA - 68258-3030-1 - (zanamivir)

Alphabetical Index


Drug Information of RELENZA

Product NDC: 68258-3030
Proprietary Name: RELENZA
Non Proprietary Name: zanamivir
Active Ingredient(s): 5    mg/1 & nbsp;   zanamivir
Administration Route(s): RESPIRATORY (INHALATION)
Dosage Form(s): POWDER
Coding System: National Drug Codes(NDC)

Labeler Information of RELENZA

Product NDC: 68258-3030
Labeler Name: Dispensing Solutions Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021036
Marketing Category: NDA
Start Marketing Date: 20021222

Package Information of RELENZA

Package NDC: 68258-3030-1
Package Description: 5 PACKAGE in 1 CARTON (68258-3030-1) > 4 POWDER in 1 PACKAGE

NDC Information of RELENZA

NDC Code 68258-3030-1
Proprietary Name RELENZA
Package Description 5 PACKAGE in 1 CARTON (68258-3030-1) > 4 POWDER in 1 PACKAGE
Product NDC 68258-3030
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name zanamivir
Dosage Form Name POWDER
Route Name RESPIRATORY (INHALATION)
Start Marketing Date 20021222
Marketing Category Name NDA
Labeler Name Dispensing Solutions Inc.
Substance Name ZANAMIVIR
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA]

Complete Information of RELENZA


General Information